3 No-Brainer Stocks to Buy in September
Don't want to think too hard about your investing decisions? Then go with the stocks of highly profitable companies with strong growth prospects.
Three Motley Fool contributors identified several stocks that fit this description. Here's why they think Eli Lilly (NYSE: LLY), Novo Nordisk (NYSE: NVO), and Vertex Pharmaceuticals (NASDAQ: VRTX) are no-brainer healthcare stocks to buy in September.
David Jagielski (Eli Lilly): Eli Lilly continually gives investors reason to become even more bullish on its already plentiful growth opportunities. Right now, it's all about the growing upside and potential for tirzepatide -- the active ingredient in its type 2 diabetes and weight loss drugs, Mounjaro and Zepbound.
Source Fool.com
Vertex Pharmaceuticals Inc. Aktie
428,15 €
1,28 %
Vertex Pharmaceuticals Inc. sticht hervor mit 59 Buy- und nur 2 Sell-Einschätzungen.
Das Kursziel von 450 € für Vertex Pharmaceuticals Inc. zeigt eine leichte Steigerung gegenüber dem aktuellen Kurs von 428.15 € an.
